Selank: Researching the Anxiolytic Peptide Analog of Tuftsin

04/03/2026 | Bio Bulk Peptides |

Technical Specifications

  • Molecular Formula: C33H57N11O9
  • Molecular Weight: 751.9 g/mol
  • Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro (L-Threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolyl-glycyl-L-proline)
  • CAS Number: 129954-34-3
  • PubChem CID: 11765600
  • Purity: >98% (as established via HPLC)
  • Physical State: Lyophilized powder

Overview of Selank

Selank is a synthetic heptapeptide categorized as an anxiolytic (anxiety-reducing) agent with potential nootropic (cognitive-enhancing) properties. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it was engineered as a stable analog of the naturally occurring tetrapeptide tuftsin.

Tuftsin (Thr-Lys-Pro-Arg) is a physiological peptide produced in the spleen that plays a critical role in the human immune response. While tuftsin possesses immunomodulatory properties, its clinical utility is limited by a very short half-life in the bloodstream due to rapid degradation by proteolytic enzymes. To overcome these metabolic hurdles, researchers elongated the tuftsin sequence by adding a tripeptide, Pro-Gly-Pro, to its C-terminus. This modification resulted in Selank, a compound that retains the biological activity of its parent molecule while exhibiting significantly enhanced metabolic stability and the ability to cross the blood-brain barrier.

In research settings, Selank is distinguished from traditional anxiolytics, such as benzodiazepines, by its unique mechanism of action. It has been investigated for its ability to reduce stress-related behaviors without inducing the typical side effects of sedation, muscle relaxation, or cognitive impairment.

Mechanism of Action: GABAergic Modulation

The primary pharmacological profile of Selank centers on its interaction with the gamma-aminobutyric acid (GABA) system. GABA is the primary inhibitory neurotransmitter in the mammalian central nervous system, responsible for maintaining neurological "tone" and preventing over-excitation of neurons.

Positive Allosteric Modulation

Unlike many synthetic compounds that act as direct GABA agonists, research suggests that Selank functions as a positive allosteric modulator of the GABA_A receptor. This means the peptide does not bind to the same site as GABA itself; instead, it binds to a secondary (allosteric) site. This binding causes a conformational change in the receptor, increasing its affinity for GABA.

By enhancing the efficiency of endogenous GABA, Selank facilitates the opening of chloride ion channels, leading to hyperpolarization of the postsynaptic neuron. This action effectively "muffles" the transmission of excitatory signals, which is the foundational mechanism for its observed anxiolytic effects in laboratory models.

Neural connections illustrating GABA modulation and inhibitory signaling in Selank research.

Comparison with Benzodiazepines

While both Selank and benzodiazepines interact with the GABAergic system, their molecular footprints differ. Benzodiazepines typically bind to a specific subunit of the GABA_A receptor that is associated with both anxiolysis and sedation. Selank appears to demonstrate a more selective influence on GABAergic neurotransmission, favoring the reduction of anxiety without the hypnotic or motor-impairing effects often noted in benzodiazepine research. Furthermore, preclinical studies have not indicated the development of tolerance or withdrawal symptoms typically associated with traditional anxiolytic medications.

Influence on Neurotransmitters and Enkephalins

Beyond its interaction with GABA, Selank has been observed to influence several other biochemical pathways, contributing to a multi-faceted neuro-regulatory profile.

  • Dopamine and Serotonin Stabilization: Research indicates that the administration of Selank may modulate the levels of serotonin (5-HT) and dopamine in the brain, particularly in the hypothalamus and hippocampus. These neurotransmitters are integral to mood regulation, reward processing, and cognitive function.
  • Enkephalin Degradation Inhibition: Selank has been shown to inhibit the activity of enkephalin-degrading enzymes (such as carboxypeptidase H and enkephalinase). Enkephalins are endogenous opioid peptides that act as natural "painkillers" and mood stabilizers. By preventing their breakdown, Selank may prolong their inhibitory effects on stress and pain signaling.
  • Brain-Derived Neurotrophic Factor (BDNF): In certain research models, the peptide has been linked to an increase in the expression of BDNF, a vital protein for the survival, growth, and differentiation of neurons. This suggests a potential role in long-term neuroprotection and neuroplasticity.

Research Applications in Cognition and Memory

A significant area of interest for researchers involves the nootropic potential of Selank. While many anxiolytics impair memory formation (anterograde amnesia), Selank has been studied for its ability to enhance cognitive processes, especially under conditions of acute stress.

Learning and Memory Enhancement

In animal models, Selank has been observed to accelerate the formation of conditioned reflexes and improve the stability of memory traces. This is theorized to be a result of its influence on the hippocampus, a region of the brain critical for spatial navigation and the consolidation of information from short-term memory to long-term memory.

Abstract spiral depicting memory organization and cognitive enhancement in Selank studies.

Neuroprotection

Exploring the neuroprotective capabilities of Selank involves investigating its role in mitigating oxidative stress and inflammation within neural tissues. By stabilizing neurotransmitter levels and potentially upregulating neurotrophic factors, the peptide is a subject of research for its ability to preserve neural integrity against metabolic or environmental insults.

Metabolic Stability and Peptide Design

The engineering of Selank serves as a benchmark for peptide-based drug design. The original tuftsin peptide is highly susceptible to aminopeptidases. The addition of the Pro-Gly-Pro sequence at the C-terminus provides several advantages in a research context:

  1. Proteolytic Resistance: The proline-rich sequence protects the peptide from rapid enzymatic cleavage, allowing it to persist in the system long enough to reach target receptors in the brain.
  2. Bioavailability: This modification enhances the peptide's ability to remain intact during transport, which is a major hurdle in the research of therapeutic peptides.
  3. Blood-Brain Barrier Penetration: The small molecular size and specific sequence allow for efficient crossing of the blood-brain barrier, a prerequisite for any centrally acting compound.

Selank in the Context of Modern Peptide Research

As researchers continue to explore the complexities of the central nervous system, compounds like Selank provide a valuable tool for understanding how small peptide chains can exert significant regulatory control over behavior and cognition. Its derivation from tuftsin underscores the potential of utilizing endogenous biological templates to create synthetic analogs with refined characteristics.

While peptides like SMG-1, TZP-2, and RTA-3 are frequently studied for their metabolic and weight-management properties (see our products at https://biobulkpeptides.com/products), Selank represents a distinct branch of research focused on neurology and psychopharmacology.

Laboratory vial with a stylized Selank peptide chain for neurological research applications.

Storage and Reconstitution

To maintain the structural integrity and biological activity of Selank, proper handling is required:

  • Storage (Lyophilized): The powder should be stored at -20°C for long-term stability. It can be kept at 4°C for shorter periods (up to several weeks).
  • Reconstitution: Use bacteriostatic water or sterile saline for reconstitution.
  • Storage (Reconstituted): Once in solution, the peptide is highly sensitive. It must be stored at 4°C and should be used within a timeframe established by the research protocol (typically 7–14 days).
  • Avoid Agitation: When reconstituting, do not shake the vial; gently swirl to dissolve the powder to avoid denaturing the peptide.

Disclaimer

FOR RESEARCH USE ONLY. This compound is intended strictly for laboratory and research applications. It is not for human or animal consumption. Selank is not a drug, food, or cosmetic and may not be misbranded or misused as such. The information provided here is for educational purposes and is based on preclinical research. No claims are made regarding the safety or efficacy of this compound in humans. All researchers must follow strict laboratory safety protocols and local regulations.

Not for human use. For research purposes only.

Summary of Key Research Areas

Feature Research Observation
Primary Target GABA_A Receptor (Allosteric Modulation)
Parent Molecule Tuftsin (Spleen-derived immunomodulator)
Anxiolytic Profile Non-sedative, non-hypnotic, no motor impairment
Neuroplasticity Potential upregulation of BDNF
Cognitive Influence Enhancement of memory consolidation and learning
Stability Enhanced via Pro-Gly-Pro C-terminus modification

Researchers interested in acquiring high-purity peptides for laboratory use may review our Certificate of Analysis (COA) data at https://biobulkpeptides.com/coa-s or visit our main catalog at https://biobulkpeptides.com. For any inquiries regarding technical specifications or bulk research requirements, please contact us.